Skip to content
The Policy VaultThe Policy Vault

Bosulif (bosutinib tablets and capsules) — Cigna

Myeloid/Lymphoid Neoplasms with Eosinophilia (ABL1 rearrangement)

Initial criteria

  • Patient age ≥ 18 years
  • Tumor has an ABL1 rearrangement

Approval duration

1 year